Treatment of Fat Embolism: Respiratory Support, Hemodynamic Stabilisation, and Oxygenation Targets
Clinical Scenario
Fat embolism syndrome involves dysfunction across multiple organ systems — most prominently respiratory failure, cardiovascular compromise, and cerebral dysfunction. Management is symptom-directed and targets each affected system in sequence.
Treatment Approach (Partial Overview)
Once the syndrome develops, clinical dysfunction is treated symptomatically. Respiratory support — ranging from supplemental oxygen to ventilatory assistance for more severe presentations — forms the cornerstone of initial management. Cardiovascular and right heart function also require system-specific directed care. The full structured regimen, including the complete approach to each organ system, is available via the protocol below.
Key Oxygenation Targets
PaO₂ ≥ 60 mmHg
SaO₂ ≥ 90%
References
- Once the syndrome develops, the clinical dysfunction is treated symptomatically.
- Initial respiratory dysfunction is managed using supplemental oxygen to prevent hypoxemia.
- Respiratory failure (ARDS/ALI) is managed by ventilatory support modes.
- Inotropes (epinephrine, norepinephrine, vasopressin, phenylephrine) and fluids are typically used to manage intraoperative hypotension and cardiovascular collapse.
- Management of right heart failure secondary to increased pulmonary hypertension is challenging.
- In addition to inotropic support, it may require specific pulmonary vasodilators.
- Management of cerebral dysfunction is primarily supportive, with the aim of optimizing the intracranial pressure, cerebral perfusion pressure, and oxygen delivery.
- Hypoxemia (room air SaO₂ <90%) is also common (50%–90%) after major long bone injuries, and is attributed to subclinical FES.
- A blood gas analysis performed at room air will often reveal a PaO₂ of less than 60 mm Hg.
View source ↗